Nunzia Pharmaceutical Company
NUNZ
$0.00
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6,980.00% | 240.00% | -69.88% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 896.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 686.67% | 647.50% | -69.88% | -- | -- |
|
|
|||||
| Total Current Assets | 686.67% | 647.50% | -69.88% | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 272.63% | 232.22% | -69.88% | -- | -- |
|
|
|||||
| Total Accounts Payable | 286.61% | -71.54% | -80.00% | -92.66% | -54.84% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 827.62% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 723.81% |
| Total Other Current Liabilities | -- | -- | -- | -- | 723.81% |
| Total Current Liabilities | 132.04% | 134.93% | 99.85% | 172.80% | 176.77% |
|
|
|||||
| Total Current Liabilities | 132.04% | 134.93% | 99.85% | 172.80% | 176.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 827.62% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 87.82% | 134.93% | 49.73% | 67.17% | 241.93% |
|
|
|||||
| Common Stock & APIC | 95.70% | 70,040.74% | 114.60% | 94.35% | 36,911.81% |
| Retained Earnings | -95.64% | -2,014.21% | -95.47% | -77.02% | -28,931.55% |
| Treasury Stock & Other | 0.00% | -99.65% | -99.65% | -99.65% | -21.53% |
| Total Common Equity | -72.03% | -118.62% | -76.17% | -58.59% | -215.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -72.03% | -118.62% | -76.17% | -58.59% | -215.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -72.03% | -118.62% | -76.17% | -58.59% | -215.01% |
|
|
|||||